These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 14560574
61. Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Au WY, Chan EC, Siu LL, Lau TC, Lie AK, Ma SK, Kwong YL. Br J Haematol; 2002 Dec; 119(3):777-80. PubMed ID: 12437659 [Abstract] [Full Text] [Related]
64. Immunodeficiency after allogeneic bone marrow transplantation in man: the role of antigen presenting cells. Møller J, Dickmeiss E, Jacobsen N, Svejgaard A. Tokai J Exp Clin Med; 1996 Feb; 21(1):13-7. PubMed ID: 9239799 [Abstract] [Full Text] [Related]
65. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma. Hidalgo Lopez JE, Yabe M, Carballo-Zarate AA, Wang SA, Jorgensen JL, Ahmed S, Lee J, Li S, Schlette E, McDonnell T, Miranda RN, Medeiros LJ, Bueso-Ramos CE, Yin CC. J Natl Compr Canc Netw; 2016 Aug; 14(8):939-44. PubMed ID: 27496109 [Abstract] [Full Text] [Related]
66. Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia. Humblet-Baron S, Baron F, Beguin Y, Chachati A, Bury J, Morelon E, Kreis H. Transplantation; 2003 Nov 27; 76(10):1531-2. PubMed ID: 14657702 [No Abstract] [Full Text] [Related]
69. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L. Ann Med; 2008 Nov 27; 40(6):444-55. PubMed ID: 18608121 [Abstract] [Full Text] [Related]
70. [Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia]. Okamura K, Ikeda T, Shimakura Y, Yoshiba F, Kishi K, Ando K, Hotta T. Rinsho Ketsueki; 2005 Jul 27; 46(7):527-31. PubMed ID: 16440747 [Abstract] [Full Text] [Related]
71. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K. Biol Blood Marrow Transplant; 2005 Feb 27; 11(2):122-8. PubMed ID: 15682073 [Abstract] [Full Text] [Related]
78. Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. Berg KD, Brinster NK, Huhn KM, Goggins MG, Jones RJ, Makary A, Murphy KM, Griffin CA, Rosenblum-Vos LS, Borowitz MJ, Nousari HC, Eshleman JR. N Engl J Med; 2001 Nov 15; 345(20):1458-63. PubMed ID: 11794194 [No Abstract] [Full Text] [Related]
79. Ureteral obstruction following allogeneic bone marrow transplantation in children. Tagliabue A, Vallinoto C, Corti P, Nicolini B, Rovelli A, Balduzzi A, Uderzo C. Pediatr Hematol Oncol; 2003 Nov 15; 20(3):257-60. PubMed ID: 12637223 [Abstract] [Full Text] [Related]